Transbronchial Lung Cryobiopsy for Interstitial Lung Disease Diagnosis: Results of the COLDICE Study

Troy, Lauren; Grainge, Christopher; Corte, Tamera J.; Williamson, Jonathan; Vallely, Michael P.; Cooper, Wendy A.; Mahar, Annabelle; Lai, Simon; Mulyadi, Ellie; Torzillo, Paul J.; Phillips, Martin J.; Jo, Helen; Webster, Susanne; Lin, Qi; Rhodes, Jessica; Salamonsen, Matthew; Wrobel, Jérémy; Harris, Benjamin; Don, Garrick; Wu, Peter; Ng, Benjamin; Oldmeadow, Christopher; Raghu, Ganesh; Lau, Edmund

doi:10.2139/ssrn.3420429

Search citation statements

Order By: Relevance

Paper Sections

Select...

Discussion1

Ilds/dplds Of Known Origin1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2020

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In addition, the authors acknowledge that some patients had a diagnosis based on cryobiopsy or TBLB, which is currently not recommended by IPF guidelines. However, cryobiopsy has been shown to be useful for the diagnosis of ILD on the recent COLDICE study [ 22 ] and it is unclear whether a TBLB-based molecular classifier would overrule results of cryobiopsy and have less potential adverse effects.…”

Section: Discussionmentioning

confidence: 99%

Updates in using a molecular classifier to identify usual interstitial pneumonia in conventional transbronchial lung biopsy samples

Crespo

Alfaro

Somogyi

et al. 2020

Breathe

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Updates in using a molecular classifier to identify usual interstitial pneumonia in conventional transbronchial lung biopsy samples

Crespo

Alfaro

Somogyi

et al. 2020

Breathe

View full text Add to dashboard Cite

show abstract

“…Yet, due to the negative primary end-point, effects have to be interpreted with caution. The multicentric COLDICE study assessed the agreement between transbronchial lung cryobiopsy (TBLC) and surgical lung biopsy and found a high level of agreement (weighted κ 0.70, 95% CI 0.55-0.86) [28]. The use of TBLC for ILD diagnosis is thus supported.…”

Section: Ilds/dplds Of Known Originmentioning

confidence: 98%

ERS International Congress, Madrid, 2019: highlights from the Interstitial Lung Diseases Assembly

et al. 2020

View full text Add to dashboard Cite

This article discusses a selection of the scientific presentations in the field of interstitial lung diseases (ILDs) that took place at the 2019 European Respiratory Society International Congress in Madrid, Spain. There were sessions from all four groups within Assembly 12: group 12.01 “Idiopathic interstitial pneumonias”, group 12.02 “ILDs/diffuse parenchymal lung diseases (DPLDs) of known origin”, group 12.03 “Sarcoidosis and other granulomatous ILDs/DPLDs” and group 12.04 “Rare ILDs/DPLDs”. The presented studies brought cutting-edge developments on several aspects of these conditions, including pathogenesis, diagnosis and treatment. As many of the ILDs are individually rare, the sharing of experiences and new data that occur during the Congress are very important for physicians interested in ILDs and ILD patients alike.

show abstract

Transbronchial Lung Cryobiopsy for Interstitial Lung Disease Diagnosis: Results of the COLDICE Study

Cited by 2 publications

References 0 publications

Updates in using a molecular classifier to identify usual interstitial pneumonia in conventional transbronchial lung biopsy samples

Updates in using a molecular classifier to identify usual interstitial pneumonia in conventional transbronchial lung biopsy samples

ERS International Congress, Madrid, 2019: highlights from the Interstitial Lung Diseases Assembly

Contact Info

Product

Resources

About